Literature DB >> 9817890

Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994.

M E Klepser1, M A Pfaller.   

Abstract

Ninety-eight isolates of Cryptococcus neoformans were collected from 30 patients at the University of Iowa Hospitals and Clinics from December 1987 through December 1994. The susceptibility of each isolate was determined against fluconazole, itraconazole, amphotericin B, and flucytosine. Of the 98 isolates, 53 were recovered from blood, 19 were recovered from cerebrospinal fluid (CSF), and 26 were recovered from other sources. Although the strains were isolated from the same institution, DNA typing by electrophoretic karyotype (EK) revealed wide genetic variation. Overall, 23 different EK profiles were identified by computer-aided analysis. An isolate exhibiting a single EK was isolated from 24 of 30 patients (80%), whereas multiple strains with unique EKs were isolated from 6 of 30 (20%) patients. Of the six patients who had multiple strains recovered, only one individual had two strains isolated from unique body sites, one strain from the blood and the other from the CSF. Six strains were isolated from multiple patients. Nine patients had multiple sequential isolates recovered over periods of time ranging from 3 days to 4 months. EK analysis revealed persistence of the same genotype in six of the cases. Three patients, however, appeared to have an isolate with a second distinct EK emerge during therapy. Of the patients with sequential positive cultures, an increase in the MICs for test agents was observed in only one case. C. neoformans isolates were collected over a period of 7 years, during which time MICs at our institution remained stable.

Entities:  

Mesh:

Year:  1998        PMID: 9817890      PMCID: PMC105257     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.

Authors:  C M van der Horst; M S Saag; G A Cloud; R J Hamill; J R Graybill; J D Sobel; P C Johnson; C U Tuazon; T Kerkering; B L Moskovitz; W G Powderly; W E Dismukes
Journal:  N Engl J Med       Date:  1997-07-03       Impact factor: 91.245

2.  Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.

Authors:  F Barchiesi; R J Hollis; S A Messer; G Scalise; M G Rinaldi; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1995-11       Impact factor: 2.803

3.  Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group.

Authors:  M E Brandt; M A Pfaller; R A Hajjeh; E A Graviss; J Rees; E D Spitzer; R W Pinner; L W Mayer
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

4.  Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting.

Authors:  K A Haynes; D J Sullivan; D C Coleman; J C Clarke; R Emilianus; C Atkinson; K J Cann
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

5.  Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.

Authors:  E D Spitzer; S G Spitzer; L F Freundlich; A Casadevall
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

6.  Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group.

Authors:  R N Jones; S A Marshall; M A Pfaller; W W Wilke; R J Hollis; M E Erwin; M B Edmond; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1997-10       Impact factor: 2.803

7.  Diversity of DNA fingerprints in Cryptococcus neoformans.

Authors:  A Varma; D Swinne; F Staib; J E Bennett; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

8.  Karyotype instability in Cryptococcus neoformans infection.

Authors:  B C Fries; F Chen; B P Currie; A Casadevall
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

  8 in total
  15 in total

1.  It infects me, it infects me not: phenotypic switching in the fungal pathogen Cryptococcus neoformans.

Authors:  C A D'Souza; J Heitman
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Electrophoretic karyotypes of C. neoformans serotype A recovered from Thai patients with AIDS.

Authors:  Puriya Ngamwongsatit; Samaniya Sukroongreung; Churairatana Nilakul; Virapong Prachayasittikul; Srisurang Tantimavanich
Journal:  Mycopathologia       Date:  2005-02       Impact factor: 2.574

3.  Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.

Authors:  J Xu; C Onyewu; H J Yoell; R Y Ali; R J Vilgalys; T G Mitchell
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 4.  The Evolution of Sexual Reproduction and the Mating-Type Locus: Links to Pathogenesis of Cryptococcus Human Pathogenic Fungi.

Authors:  Sheng Sun; Marco A Coelho; Márcia David-Palma; Shelby J Priest; Joseph Heitman
Journal:  Annu Rev Genet       Date:  2019-09-19       Impact factor: 16.830

5.  Molecular epidemiology of clinical Cryptococcus neoformans strains from India.

Authors:  N Jain; B L Wickes; S M Keller; J Fu; A Casadevall; P Jain; M A Ragan; U Banerjee; B C Fries
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India.

Authors:  Piyali Mandal; Uma Banerjee; Arturo Casadevall; Joshua D Nosanchuk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Phenotypic switching and genetic diversity of Cryptococcus neoformans.

Authors:  S Sukroongreung; S Lim; S Tantimavanich; B Eampokalap; D Carter; C Nilakul; S Kulkeratiyut; S Tansuphaswadikul
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).

Authors:  M A Pfaller; S A Messer; L Boyken; C Rice; S Tendolkar; R J Hollis; G V Doern; D J Diekema
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 9.  Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Neena Jain; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

10.  Cryptococcus neoformans capsule structure evolution in vitro and during murine infection.

Authors:  Dea Garcia-Hermoso; Françoise Dromer; Guilhem Janbon
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.